TrialInternational urology and nephrology2012

Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism.

Tomasz Hryszko et al.PubMed ↗Publisher ↗

No numbers read from the abstract.